IPO Trending
GLANDSME / NSE, BSEListed
Gland Pharma

Founded in Hyderabad, India, in 1978, Gland Pharma has evolved from a small-scale contract manufacturer to one of the largest and fastest-growing injectable-focused companies. It has a global presence in 60 countries, including the United States, Europe, Canada, Australia, and India. Operating primarily under a B2B model, Gland Pharma has a strong track record in developing, manufacturing, and marketing complex injectables. Its integrated presence across the value chain has fueled rapid growth. The company is promoted by Shanghai Fosun Pharma, a leading global pharmaceutical company.

DRHP
₹1,490 - ₹1,500Open
Listed Price₹1710.00
Listing Gain+14.00%

IPO Schedule & Timeline

Bookbuilding IPO
Open09 Nov 2020
Close11 Nov 2020
Allotment18 Nov 2020
Listing20 Nov 2020

Quota Reservation & Application Lots

Quota Reservation (% Shares)

QIB2,15,98,483 shares
50%
HNI64,79,546 shares
15%
Retail1,51,18,939 shares
34%

Minimum Application Lots

Retail1 Lot (10 shares)
₹15,000
sHNI14 Lots (140 shares)
₹2,10,000
bHNI67 Lots (670 shares)
₹10,05,000

Company Promoters

Fosun Pharma Industrial Pte. LtdShanghai Fosun Pharmaceutical (Group) Co. Ltd

Company Background

Founded in Hyderabad, India, in 1978, Gland Pharma has evolved from a small-scale contract manufacturer to one of the largest and fastest-growing injectable-focused companies. It has a global presence in 60 countries, including the United States, Europe, Canada, Australia, and India. Operating primarily under a B2B model, Gland Pharma has a strong track reco...

Lead Managers & Bankers

Citigroup Global Markets India Private LimitedHaitong Securities India Private LimitedKotak Mahindra Capital Company LimitedNomura Financial Advisory And Securities (India) Private Limited

Financial Performance

Figures in ₹ Crores
Metric Breakdown

Revenue

Latest (June-20)₹9162.89 Cr
Growth-45.2%
Revenue Trend (₹ in Crores)
0.010.6k21.3k31.9kMar-18Mar-19Mar-20June-20
PeriodRev (Cr)PAT (Cr)AssetsDebt
June-209,162.893,135.9046,912.650
Mar-2027,724.087,728.5840,860.390
Mar-1921,297.674,518.5635,235.490
Mar-1816,716.823,210.5129,294.680

Broker & Analyst Reviews

Review Not Available

Institutional broker reviews and analyst reports have not been released for this issue yet. Reviews are typically published 2 to 3 days prior to the issue opening date.

IPO Allotment & Registrar Status

Official Registrar: Link Intime India Private Limited

Allotment Finalized
Allotment Date
18 Nov 2020
Official Status
Out / Finalized
Registrar
Link Intime India Private Limited
Listing Date
20 Nov 2020

Official Allotment Verification Links

Official Registrar Portal
Link Intime India Private Limited

Direct allotment verification on the official registrar portal appointed for Gland Pharma. Check with PAN or Application No.

Check on Registrar Portal
Stock Exchange Portal
BSE India Investor Portal

Official Bombay Stock Exchange investor verification channel using Issue Name and PAN Number.

Check on BSE India

Allotment Schedule & Milestones

IST
1. Allotment Finalization18 Nov 2020Basis of allotment declared
2. Refund Initiation1 day post allotmentUPI / ASBA mandate unblocked
3. Demat CreditPrior to listingShares credited to CDSL/NSDL
4. Listing Date20 Nov 2020Trading commences on exchange

How to Check Gland Pharma Allotment Online

1Open Portal

Click on the official registrar link or BSE portal button above.

2Select Company

Select Gland Pharma from the issue drop-down list.

3Enter Details

Select PAN, Application No., or DP Client ID and type your details.

4View Allocation

Click Submit to check your allotted share count and status.

Prospectus & Official Filings

Official FilingDRHP

Allotment FAQs & Help

About Gland Pharma IPO

Complete issue overview for Gland Pharma (GLAND) IPO. The issue features an equity share price band of ₹1490 – ₹1500 per share with a minimum retail lot size of 10 Shares (minimum application amount of ₹15,000). Explore live market tracking on our GMP Tracker, compare against All IPO GMP Today, or view category bidding on the Subscription Page. Verify official allotment via IPO Registrars or review participating investment bankers in our Lead Managers Directory.

Frequently Asked Questions